Formulary

O/W Caring Body Lotion

Released by Evonik Corporation - Personal Care business line

May 1, 2011


Phase A
Tegin 4100 pellets(Glyceryl stearate)
.50
Stearic acid
.50
Tegosoft OP (Ethylhexyl palmitate) 5.00
5.00
Tegosoft P (Isopropyl palmitate) 6.00
6.00
Tegosoft DC (Decyl cocoate) 3.00
3.00
Tegosoft CR (Cetyl ricinoleate)
2.00
Tego Care CG 90 (Cetearyl glucoside)
1.00
Tego carbomer 141 G
0.20
Glycerin
2.00
Panthenol
0.50

Phase B
Water
74.30

Phase C
Sodium hydroxide (10% in water) q.s.

Phase D
Alcohol
5.00

Phase Z
Preservative, perfume q.s.

More Information
Combine ingredients of phase B and heat to approximately 80°C. Homogenize in order to dissolve the Tego Carbomer 141 G. Heat phase A to approx. 80°C. Add phase A to phase B with stirring. Important: If phase A has to be charged into the vessel first, phase B must be added without stirring. Homogenize. Cool with gentle stirring and add phase C and D below 40°C.

More Information

Evonik Goldschmidt GmbH

+49 201 173-2854 u2022 Fax: +49 201 173-1828

Email: personal-care@evonik.com

Website: www.evonik.com/personal-care


Related End-User Markets:

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna , Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • Perform or Perish

    Perform or Perish

    Christine Esposito, Associate Editor||December 1, 2016
    Success in today’s skin care sector begins with active ingredients, formulated in products that address modern-day issues.

  • Soap Opera

    Soap Opera

    Christine Esposito, Associate Editor||November 2, 2016
    FDA’s recent antibacterial ruling has soap sector stakeholders scrambling to keep some ingredients in their formulation kit.